VRTX card
VRTX price forecast
Vertex Pharmaceuticals$537,79
P/E now is 34,6. Average over 5 years: 27,6 (range 25–30). The stock is 25% above its history.
Base · FY2030
$673,74+5,6% a year
The base case gives 5,6% a year, below your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2030$673,74+5,6% a year